ClinicalTrials.Veeva

Menu

Late Biomarkers in Adult Survivors After Out-of-hospital Cardiac Arrest

R

Region Skane

Status

Not yet enrolling

Conditions

Cardiac Arrest, Out-Of-Hospital

Study type

Observational

Funder types

Other

Identifiers

NCT06587763
STEPCARE late biomarker study

Details and patient eligibility

About

Blood samples are collected at six months follow-up from adult survivors after out-of-hospital cardiac arrest. Patients will be informed about the study and if they consent to participation, venous blood will be drawn by authorised medical personnel. Plasma, serum and PAX-RNA will be collected (ca 15 ml in total), processed and frozen for analysis after trial completion.

Full description

Blood samples are collected at six months follow-up from adult survivors after out-of-hospital cardiac arrest. Patients will be informed about the study and if they consent to participation, venous blood will be drawn by authorised medical personnel. Plasma, serum and PAX-RNA will be collected (ca 15 ml in total), processed and frozen for analysis after trial completion.

Samples will be analysed in batch for biomarkers of brain injury, inflammation etc.

Primary outcome is functional outcome (modified Rankin Scale 4-6) at six months after cardiac arrest.

Secondary outcomes are neurocognitive function according to the Montreal Cognitive Assessment (MoCA), Symbol Digits Modalities Test (SDMT).

Enrollment

400 estimated patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Survivors of out-of-cardiac arrest who participate in the extended follow-up study of the STEPCARE trial at selected sites only

Exclusion criteria

  • Patients not participating in the extended follow-up at participating sites

Trial contacts and locations

3

Loading...

Central trial contact

Marion Moseby-Knappe, MD, PhD; Niklas Nielsen, Prof

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems